Research & Tips

Spread Betting and CFD trading carry a high level of risk to your capital; you should ensure you understand the risks involved. Please read the full risk warning.

Share research from Hargreaves Lansdown

  • Anglo American - Reinstating the dividend payment
    30 Jul, 2010 12:55
    The group’s half year results (30July2010) saw the company reporting good progress. Economic recovery in many parts of the world helped the group report a 104pc increase in operating profit to $4.36 billion. Group restructuring and cost savings initiatives all contributed, with management now confident enough to reinstate the dividend payment – axed during the depths of the financial crisis. The company’s sale of what are now seen as non-core businesses also remained ongoing - the already announced sales of

  • Royal Dutch Shell - Restructuring and cutting costs
    29 Jul, 2010 14:00
    The group’s second quarter/half year results (29July2010) generally exceeded analysts’ forecasts. Second quarter profit on a current cost of supply basis (a figure which strips out gains or losses from inventories and other non-operating items) increased by 95pc to $4.53 billion against that achieved in Q2 2009 ($2.3 billion). Assisted by a rising oil price, group restructuring measures continued to gain traction – costs of just over $3.5 billion on an annualised basis were removed over the period, with some

  • AstraZeneca - Enjoying emerging market momentum
    29 Jul, 2010 13:25
    The group’s second quarter/half year results (29July2010) materialised at the high end of analysts’ expectations. Pre-tax profit during the quarter rose by 10pc on a constant currency basis to $2.91 billion, whilst earnings per share came in at 179 US cents. The group’s core brands - Crestor, Seroquel and Symbicort – continued to enjoy strong performances, whilst emerging market sales again saw positive momentum (+16pc) – this compared to an increase of 1pc in Western Europe. In addition to

Press tips from Share Cast

  • Friday tips round-up: Rolls-Royce, Aegis, Travis Perkins
    30 Jul, 2010 06:55
    Rolls-Royce is among the FTSE 100's band of defensives. The shares trade on a multiple of 15.5 times forecast earnings for 2010, putting the stock at the top of end of its historic range.

  • Thursday tips round-up: BP, BG, Sage
    29 Jul, 2010 06:08
    BP unveiled a $32.2bn (£20.7bn) charge related to the oil spill on Tuesday. This is not a full and final figure for the costs involved in the catastrophe, but a rough assessment. The Telegraph feels that a hold rating on the shares is appropriate. If you

  • Wednesday tips round-up: Misys, Arm, Croda
    28 Jul, 2010 06:53
    Reckitt Benckiser is looking for more bolt-on acquisitions in the health and personal care area - and SSL is an excellent purchase, although at £2.54bn it cannot be described as cheap.

Broker tips from Share Cast

  • Broker tips: BAE Systems, Pace, Partygaming
    30 Jul, 2010 13:17
    Strong results and upgraded full year profits guidance has not been enough to overcome investor concerns about future prospects for BAE Systems, a situation acknowledged by Nomura Securities' decision to slice its price target for the defence systems firm

  • Broker snap: Pace purchase makes strategic sense
    30 Jul, 2010 13:15
    Having met with the management of digital set-top box maker Pace in the wake of the company's interim results finnCap has nudged up its fiscal 2010 earnings estimates.

  • Broker snap: bwin a good match for Party
    30 Jul, 2010 13:01
    Scale matters in online gaming which is why Peel Hunt is a fan of Partygaming's proposed merger with Austrian rival Bwin, describing it as potentially 'a match made in heaven.'

Directors dealings from Share Cast

Client Log In


HL Markets in partnership with IG Index

Client Login

Log in

Lost your login details?

 

iPhone Log In

Do you have an iPhone?
Log in to the iPhone-friendly
platforms below.

Spread Betting login

CFD login

Market latest

FTSE 100 today
Intraday price for FTSE 100
FTSE 100 5,258.02     -1.06%
FTSE 250 9,948.72     -1.26%
FTSE All Share 2,715.36     -1.07%
Dow Jones 10,465.94     -0.01%
NASDAQ 2,254.70     +0.13%
Nikkei 9,537.30     -1.66%
Hang Seng 21,029.81     -0.30%

Contact us

No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.